ArticleFrontiers in immunology2024

FOLFOX-HAIC combined with targeted immunotherapy for initially unresectable hepatocellular carcinoma: a real-world study.

Yan-Cen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.